After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. "We'll ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Google has unveiled that healthcare provider Mayo Clinic will be the first to trial its Enterprise Search feature for building customized AI chatbots The search engine giant has made a string of ...

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

A top-of-mind question for many clinical trial workers is whether AI could lead to job loss. After all, Goldman Sachs recently estimated that 300 million jobs could be lost or degraded due to AI ...

Google's DeepMind eyes clinical trials for AI-designed drugs in 2025 - report. Jan. 21, 2025 9:39 AM ET Alphabet Inc. (GOOG) Stock, GOOGL Stock By: Ravikash Bakolia, SA News Editor 2 Comments.